Ultralife (ULBI)
NASDAQ:ULBI
Want to see ULBI full AI Analyst Report?
Earnings Data
Report Date
Apr 23, 2026Before Open (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
―Last Year’s EPS
0.11Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Q4 2025
Earnings Call Date:Jan 29, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call shows clear operational progress and improving underlying profitability metrics: revenue growth (Q4 +10.6% YoY), a strong and growing backlog (+22.1% QoQ to $110.2M), marked segment improvements in Battery & Energy (revenue +15.1%, gross margin +170 bps), and higher adjusted EBITDA (11.7% vs 8.9% prior). These positives are tempered by a sizable one-time $12.2M noncash intangible impairment that produced a GAAP operating loss and a quarter net loss, ongoing yield/efficiency issues at Newark, and a significant decline in Communications Systems revenue and margin due to timing-related order delays. Management communicated multiple concrete remediation and growth actions (Electrochem integration, facility consolidation, rebranding, product launches, and external lean support), and expects Comm Systems to rebound and Battery margins to improve in 2026. Overall, the fundamentals and forward pipeline improvements outweigh the one-time accounting charge and near-term operational headwinds.Company Guidance
Quarterly and Full-Year Revenue Growth
Q4 revenue of $48.5M, up 10.6% year-over-year; full year 2025 revenue of $191.2M with over $30M from products launched within the last 5 years (new-product revenue growth of 16.2% YoY).
Battery & Energy Segment Strength
Battery & Energy Products revenue of $45.9M, up 15.1% YoY (9.5% organic growth excluding third-party Electrochem sales). Segment gross profit increased 23.7% to $11.5M and gross margin improved 170 basis points to 25.1%.
Backlog Expansion and Health
Total backlog of $110.2M exiting Q4, up $20M or 22.1% from the prior quarter; backlog equals 58% of trailing twelve months (TTM) sales and is largely expected to ship in 2026.
Gross Profit and Margin Improvement
Consolidated gross profit of $12.1M, up 13.7% YoY; consolidated gross margin improved 70 basis points to 24.9% versus 24.2% in prior-year quarter.
Adjusted EBITDA Improvement
Adjusted EBITDA of $5.7M (11.7% of sales) in the quarter versus $3.9M (8.9% of sales) last year; TTM adjusted EBITDA of $17.3M or 9% of sales, indicating improved underlying profitability when excluding one-time/noncash items.
Operational and Strategic Progress
Completed Electrochem integration (ERP/MRP/networking), reduced North American manufacturing sites from 7 to 5, initiated global rebranding to a single Ultralife master brand, and reorganized Battery facilities into a Telemetry Power Systems division to capture synergies (reorg expected completed in Q1 2026).
Product Development Momentum and Wins
Multiple product developments moved to production or shipping: conformal wearable battery in production quantities, 19Ah Thin Cell passed validation, X5-SuperLite USB-C hot-swappable system certified and in production, A-2303 amplifier tested with initial orders, and a medical OEM battery pack with production orders scheduled mid-2026.
Debt Reduction and Liquidity
Reduced acquisition debt principal by $4.8M in 2025 (exceeding required $2.8M amortization); working capital of $68.5M and current ratio of 2.8 support liquidity needs.
ULBI Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ULBI Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Jan 29, 2026 | $6.40 | $6.47 | +1.09% |
Nov 18, 2025 | $5.54 | $5.05 | -8.84% |
Aug 07, 2025 | $8.16 | $6.77 | -17.03% |
May 09, 2025 | $4.88 | $5.05 | +3.48% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Ultralife (ULBI) report earnings?
Ultralife (ULBI) is schdueled to report earning on Apr 23, 2026, Before Open (Confirmed).
What is Ultralife (ULBI) earnings time?
Ultralife (ULBI) earnings time is at Apr 23, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ULBI EPS forecast?
Currently, no data Available